USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Meso Scale Diagnostics
Address:
1601 Research Boulevard
Rockville, MD 20850-
Phone:
N/A
URL:
N/A
EIN:
521974952
DUNS:
113033224
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,457,596.00 12
SBIR Phase II $2,658,380.00 3
STTR Phase I $199,257.00 1

Award List:

Screen for compounds to treat muscle wasting

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Meso-Scale Diagnostics (MSD) aims to discover compounds effective at inhibiting the ubiquitin E3 ligase activity of RNF28 (Murfl), a protein involved in muscle wasting. These compounds will be used to evaluate the importance of the ubiquitin E3 ligase activity in… More

SBIR TOPIC 229 PHARMACODYNAMIC ASSAY FOR CANCER THERAPEUTICS

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$149,513.00
Agency:
HHS
Principal Investigator:
Mathew Anu
Abstract:
N/a

ANTIBODY ARRAY FOR EARLY DETECTION OF LUNG CANCER

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$145,089.00
Agency:
HHS
Principal Investigator:
Stengelin Martin
Abstract:
N/a

TOPIC 238 AUTOMATED MULTI-ARRAY PLATFORM FOR CANCER BIOMARKERS

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$148,828.00
Agency:
HHS
Principal Investigator:
Glezer Eli
Abstract:
N/a

Human Proteome Arrays for Auto-Antibody Identification in Clinical Cancer Studies

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$230,965.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Human Proteome Arrays for Auto-Antibody Identification in Clinical Cancer Studies The goal of this project is to develop protein arrays on a proteome scale for high throughput discovery and validation of cancer-specific autoantibody signatures. Early detection… More

Multiplex Serology for Encephalitis

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$245,511.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The broad goal of this project is to improve the clinical diagnosis of infectious disease by advancing the current state of serological testing. Despite major advances in research techniques in microbiology, routine cli nical diagnosis of infectious diseases is… More

Multiplexed biomarker panels for early detection of prostate cancer

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$129,673.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of the proposed work is development of sensitive diagnostic serological assay panels for detection of early stage prostate cancer. Currently, the only biomarker used in prostate cancer diagnosis is the measurem ent of prostate specific antigen (PSA) in… More

Multiplex Electroluminescent Assay for Detection of Hepatocellular Carcinoma

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$199,257.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The goal of the proposed work is development of sensitive diagnostic serological assay panels for detection of hepatocellular carcinoma (HCC). Currently, the only biomarker used in HCC diagnosis is the measurement of al pha feto protein (AFP) in patient serum,… More

Human Proteome Arrays for Auto-Antibody Identification in Clinical Cancer Studies

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,101,400.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Human Proteome Arrays for Auto-Antibody Identification in Clinical Cancer Studies The goal of this project is to develop protein arrays on a proteome scale for high throughput discovery and validation of cancer-specific autoantibody signatures. Early detection… More

PHARMACODYNAMIC ASSAYS FOR WNT/FRIZZLED AND HGF/C-MET SIGNALIN

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$149,678.00
Agency:
HHS
Principal Investigator:
Anu Mathew
Abstract:
Multiplexed assays for pharmacodynamic targets of high priority for the NCI will be developed using Meso Scale Diagnostics' (MSD) Multi-Array technology to facilitate multiple integrated pharmacodynamic readouts from a single tumor biopsy or surrogate tissue specimen. These assays will be suitable… More

PHARMACODYNAMIC ASSAYS FOR CANCER THERAPEUTICS

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$756,981.00
Agency:
HHS
Principal Investigator:
Anu Mathew
Abstract:
Pharmacodynamic assays that measure levels of cellular proteins of relevance to cancer will be developed using Meso Scale Diagnostics (MSD) MULTI-ARRAY technology. These assays will be suitable for ¿real time¿ preclinical and clinical sample testing, and should allow rapid evaluation… More

ANTIBODY ARRAY FOR DETECTION OF LUNG CANCER

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$799,999.00
Agency:
HHS
Principal Investigator:
Martin Stengelin
Abstract:
The ultimate goal of the project is to develop a blood test that will significantly improve early detection of lung cancer. A high-performance multiplexed immunoassay platform will be used to evaluate biomarkers that have been associated with lung cancer in research reports. The technology enables… More

Multiplex Serum panels for Osteoarthritis and Joint Injury

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$199,766.00
Agency:
HHS
Principal Investigator:
Martin Stengelin – 240-631-2522
Abstract:
DESCRIPTION (provided by applicant): The development of a cure for osteoarthritis, the most common cause of pain and disability in the elderly, is difficult because of a lack of good diagnostics tests, in particular for early stages of the disease. Many candidate biomarkers are in various stages of… More

Non-radioactive Multiplexed Assays for Prediction/Diagnosis of T1D and Comorbid A

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$584,662.00
Agency:
HHS
Principal Investigator:
Anu Mathew – 240-631-2522
Abstract:
DESCRIPTION (provided by applicant): Type 1 Diabetes (T1D) affects an estimated one in three hundred young people in the U.S., with increasing annual incidence. It is primarily an autoimmune disease and is often associated with other serious autoimmune conditions such as Addison's, celiac, and… More

Meso Scale Diagnostics LLC

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$224,847.00
Agency:
HHS
Principal Investigator:
Jeff Debad – 240-316-2400
Abstract:
To explore the feasibility of improving the clinical diagnosis of Lyme Disease by using a multiplex diagnostic platform for laboratory-based immunoassay testing. The platform is designed for simple and fully automated use, requiring minimal hands-on time and very little training. The proposed test… More

Portable MULTI-ARRAY Test for Recent HIV Infection

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$149,064.00
Agency:
HHS
Principal Investigator:
Martin Stengelin – (240) 631-2522
Abstract:
Preventing HIV infection is a global and national priority, and a number of behavioral, vaccine-based, and drug-based strategies are the focus of intensive research. In order to accurately assess and compare different prevention strategies, HIV incidence, i.e., the rate at which new HIV infection is… More